Novozymes A/S (NSIS-B.CO)
DKK 409.4
(-0.8%)
DKK 409.4
(-0.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.15 Billion | 4 Billion | 4.06 Billion | 4.35 Billion | 3.19 Billion | 3.67 Billion |
| Net Income | 3.03 Billion | 3.68 Billion | 3.14 Billion | 2.82 Billion | 3.15 Billion | 3.22 Billion |
| Depreciation & Amortization | 1.38 Billion | 1.45 Billion | 1.37 Billion | 1.26 Billion | 1.12 Billion | 943 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 151 Million | 127 Million | 78 Million | 54 Million | 51 Million | 89 Million |
| Change in working capital | -166 Million | -583 Million | -612 Million | 311 Million | -16 Million | -582 Million |
| Other non-cash items | -5 Million | -55 Million | 34 Million | 175 Million | -1.11 Billion | 3 Million |
| Investing Cash Flow | -2.13 Billion | -2.67 Billion | -2.74 Billion | -1.52 Billion | -561 Million | -1.39 Billion |
| Investments in PPE | -2.05 Billion | -2.89 Billion | -1.24 Billion | -940 Million | -862 Million | -1.33 Billion |
| Acquisitions | -81 Million | 190 Million | -1.63 Billion | -588 Million | - | -4 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -118 Million | 165 Million | -45 Million | -142 Million | 301 Million | -56 Million |
| Financing Cash Flow | -1.88 Billion | -1.25 Billion | -1.58 Billion | -2.31 Billion | -2.64 Billion | -2.16 Billion |
| Debt repayment | -923 Million | -731 Million | -1.17 Billion | -272 Million | -779 Million | -978 Million |
| Dividends payments | -2.85 Billion | -1.52 Billion | -1.46 Billion | -1.48 Billion | -1.43 Billion | -1.31 Billion |
| Common Stock Repurchased | - | -500 Million | -1.5 Billion | -1.5 Billion | -2 Billion | -2 Billion |
| Common Stock Issuance | 167 Million | 164 Million | 309 Million | 508 Million | - | - |
| Other Financing Activities | 71 Million | 356 Million | 621 Million | 214 Million | 15 Million | 171 Million |
| Accounts receivables | -177 Million | -330 Million | -574 Million | 395 Million | -238 Million | -361 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 138 Million | -787 Million | -556 Million | 181 Million | 218 Million | -234 Million |
| Other working capital | -6 Million | -9 Million | -8 Million | 1 Million | 4 Million | 13 Million |
| Cash at beginning of period | 1.04 Billion | 963 Million | 1.18 Billion | 711 Million | 723 Million | 632 Million |
| Cash at end of period | 1.11 Billion | 1.04 Billion | 963 Million | 1.18 Billion | 711 Million | 723 Million |
| Capital Expenditure | -2.05 Billion | -2.89 Billion | -1.24 Billion | -940 Million | -862 Million | -1.33 Billion |
| Effect of forex changes on cash | -55 Million | -6 Million | 53 Million | -47 Million | -3 Million | -29 Million |
| Net cash flow / Change in cash | 75 Million | 78 Million | -218 Million | 470 Million | -12 Million | 91 Million |
| Free Cash Flow | 2.09 Billion | 1.11 Billion | 2.82 Billion | 3.41 Billion | 2.33 Billion | 2.34 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 238.31 Million | 238.32 Million | 695 Million | 3.03 Billion | 929 Million | 614 Million |
| Depreciation & Amortization | - | - | 263 Million | 1.38 Billion | 332 Million | 335 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 152 Million | 151 Million | - | - |
| Change in working capital | 725.76 Million | 725.8 Million | 427 Million | -166 Million | 219 Million | 70 Million |
| Other non-cash items | 1 Billion | 1 Billion | -117 Million | -5 Million | 226 Million | 134 Million |
| Investing Cash Flow | -204.75 Million | -204.76 Million | -603 Million | -2.13 Billion | -486 Million | -705 Million |
| Investments in PPE | -504.23 Million | -504.25 Million | -604 Million | -2.05 Billion | -475 Million | -549 Million |
| Acquisitions | 56.68 Million | 56.69 Million | -77 Million | -81 Million | -11 Million | -158 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 242.79 Million | 242.8 Million | -38 Million | -118 Million | -38 Million | -30 Million |
| Financing Cash Flow | -1.39 Billion | -1.39 Billion | -555 Million | -1.88 Billion | -977 Million | -456 Million |
| Debt repayment | - | - | -587 Million | -923 Million | -954 Million | -136 Million |
| Dividends payments | -465.81 Million | -465.84 Million | -1.19 Billion | -2.85 Billion | -1 Million | -1 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 79 Million | 167 Million | 8 Million | 9 Million |
| Other Financing Activities | -926.78 Million | -926.83 Million | 227 Million | 71 Million | -244 Million | -297 Million |
| Accounts receivables | - | - | -82 Million | -177 Million | -1 Million | 168 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 216 Million | 138 Million | 103 Million | -119 Million |
| Other working capital | 725.76 Million | 725.8 Million | -8 Million | -6 Million | -10 Million | 6 Million |
| Cash at beginning of period | - | 1.11 Billion | 1.17 Billion | 1.04 Billion | 1.04 Billion | 1.1 Billion |
| Cash at end of period | 414.35 Million | 1.53 Billion | 1.11 Billion | 1.11 Billion | 1.17 Billion | 1.04 Billion |
| Capital Expenditure | -504.23 Million | -504.25 Million | -604 Million | -2.05 Billion | -475 Million | -549 Million |
| Effect of forex changes on cash | 42.14 Million | 42.14 Million | -23 Million | -55 Million | 4 Million | -21 Million |
| Net cash flow / Change in cash | 414.35 Million | 414.37 Million | -59 Million | 75 Million | 127 Million | -52 Million |
| Free Cash Flow | 1.46 Billion | 1.46 Billion | 518 Million | 2.09 Billion | 1.11 Billion | 581 Million |
IWP
7374
5310
BATL
6980
3073